Clinical trials

#Clinical trials #Deep learning #Immunotherapy #Oncology #Start-ups

New podcast: Drug discovery success stories

This is the latest episode of the free DDW narrated podcast, “Drug discovery success stories”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Global pharma start-up success stories”, and “Excitement at rectal… Read More

#News

#Clinical trial #Clinical trial design #Clinical trials #Drug development

Free clinical trial health check to bring drugs to market faster

A new free service will offer insights in under ten days to sponsors conducting clinical trials, identifying potential ‘zombie trials’ and providing actionable recommendations for failing trials. The Health Check and Trial Rescue Service is an initiative of data software and services company Phesi. The service… Read More

#News

#Clinical trial #Clinical trials #Drug development #Drug discovery #Phase I trial

New podcast: DDW Highlights 17 October 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The buzz with week has been around Phase I trials, with new… Read More

#News

MHRA
#Clinical Trial Authorisation #Clinical trial design #Clinical trials #MHRA #Phase III trial #UK

UK regulator cuts late-stage clinical trial approval time to two weeks

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has revealed plans to reduce the time taken to approve the lowest-risk clinical trials by more than 50%. According to the plans, initial applications for the lowest-risk Phase III and IV trials will be processed by the MHRA within 14 days… Read More

#News #Regulatory

#Clinical trial #Clinical trials #Drug development #Drug discovery #Phase I trial

This week in drug discovery (9-13 October)  

News round-up for 9-13 October by DDW Digital Content Editor Diana Spencer. The buzz with week has been around Phase I trials, with new therapies for lung cancer, geographic atrophy, Parkinson’s, sarcopenia and long Covid demonstrating positive early results or entering clinical trials for the first… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trials #Imaging #Machine learning

Integration of AI in imaging clinical trials 

Sophie Winandy, Executive Director of Medical Imaging at ICON explores the benefits of AI and how it can be integrated throughout medical imaging within clinical trials.   Artificial intelligence (AI) is rapidly taking hold in the healthcare sector1, including in medical imaging, where AI often targets screening, patient eligibility, detection… Read More

#Exclusive Content

#Clinical trials #Humanisation #IBD #Mouse models

How humanized mouse models can improve outcomes for IBD

Kiave Yune Ho Wang Yin, PhD, Chief Business Officer at TransCure bioServices explores how humanized mouse models can be used to develop more relevant preclinical studies for IBD treatments and ultimately increase the likelihood of a treatment's success in clinical trials.  Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis… Read More

#Exclusive Content

Protein
#Biomarkers #Clinical trials #Collaboration #Eurofins Genomics #Olink #Partnership #Precision medicine #Proteomics

Eurofins Genomics and Olink partner to advance proteomics research

Eurofins Genomics has adopted Olink technology to advance proteomics research and accelerate its precision medicine programmes. The collaboration is designed to bolster the company’s offerings in the fields of research, population health, and regulated clinical trials. Olink Explore HT is the company's latest solution for high-throughput proteomics, allowing scientists to… Read More

#Business & Investment #News

GBP pound sterling funding
#BDD Clinical Trials #Clinical trials #Funding

£2 million secured to fuel expansion in early phase clinical trials  

Integrated drug formulation and clinical trials company, BDD Clinical Trials, has secured a further round of investment for £2M to aid the company’s expansion in response to growing demand for both its patented drug delivery technology and specialist clinical trial services.  The latest investment package follows a strong 18 months… Read More

#Business & Investment #News

Childhood Cancer Awareness Month
#Cancer research #Childhood cancer #Clinical trials #Oncology #Paediatrics

Five key studies into drugs for childhood cancers

DDW's Diana Spencer highlights five key clinical studies taking a new therapeutic approach to childhood cancers. Over 100 subtypes of childhood cancer exist today and it represents the most common cause of disease-related death in children. However, despite the fact that children’s response to adult cancer drugs is often poor,… Read More

#Cancer Research #Exclusive Content

Patient advocacy group
#Cancer #Cancer research #Clinical trial design #Clinical trials #Oncology #Patient centricity

Patient groups issue call to action on patient-centric clinical trials

A new whitepaper has introduced the concept of ‘cross-over’ options in cancer clinical trials, as a way to make trials more patient-centric in design. ‘Cross-over arms in oncology clinical trials: An important consideration for patients’ was published by the Cholangiocarcinoma Foundation (CCF) with the aim of… Read More

#News

Mouse in laboratory
#Clinical trials #Drug toxicity #Mouse models #Pharmacology #Preclinical investigations #Whitepaper

Whitepaper: Ensure accurate dose prediction for clinical trials

Accurate dose prediction for clinical trials is essential to ensure patient safety and trial success. This new whitepaper from the Jackson Laboratory discusses evidence-based selection of starting doses in first-in-human clinical trials through the utilisation of humanised mouse models. In this whitepaper you will learn about: The significance… Read More

#News

#Clinical trials #Drug toxicity #Mouse models #Pharmacology #Preclinical investigations

Discover evidence-based, first-in-human dose selection

This whitepaper discusses evidence-based selection of starting doses in first-in-human clinical trials through the utilisation of humanised mouse models and emphasises the importance of accurate dose prediction to ensure patient safety and trial success. In this whitepaper you will learn about: The significance of selecting appropriate starting doses in clinical… Read More

#Resources

Diversity
#Clinical trials #Diversity #Patient

Clinical Trials For All to educate public about clinical research

Educational campaign, Clinical Trials For All, has been launched to drive greater understanding, participation and diversity in clinical trials. Only 59% of Americans know about clinical research, 91% of Americans have never been invited to participate, and Black/African and Hispanic/Latino Americans are less than 12% of… Read More

#News

#Biotech #Cell and gene therapy #Clinical trials #Market reporting #Oncology

New podcast: A deep dive into US drug discovery

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “US biotech: Focus on positive growth… Read More

#News

Diversity
#Clinical research #Clinical trials #Diversity #Drug development #Organoids

The importance of introducing diversity earlier in drug development 

DDW’s Reece Armstrong speaks to Shantanu Dhamija, VP of Strategy and Innovation at Molecular Devices about challenges of diversity in clinical trials and why induced pluripotent stem cells might be key to representing wider patient groups.   RA: Why is US clinical trial diversity at its lowest point in the last… Read More

#Exclusive Content